108
Views
1
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Effects of Sugammadex versus Neostigmine on Intraoperative Coagulation Profiles in Patients with Thyroidectomy

, , , , & ORCID Icon
Pages 829-834 | Published online: 25 Feb 2021

References

  • Fuchs-BuderT, SchmartzD, BaumannC, et al. Deep neuromuscular blockade improves surgical conditions during gastric bypass surgery for morbid obesity: A randomised controlled trial. Eur J Anaesthesiol. 2019;36:486–493. doi:10.1097/EJA.000000000000099630985536
  • KamenV, VlassakovI, et al. A quest to increase safety of anesthetics by advancements in anesthesia monitoring: scientometric analysis. Drug design. Development Therapy. 2015;9:2599–2608.
  • KimNY, KohJC, LeeKY, et al. Influence of reversal of neuromuscular blockade with sugammadex or neostigmine on postoperative quality of recovery following a single bolus dose of rocuronium: A prospective, randomized, double-blinded, controlled study. J Clin Anesth. 2019;57:97–102. doi:10.1016/j.jclinane.2019.02.01430939422
  • GaverRS, BrennBR, GartleyA, et al. Retrospective analysis of the safety and efficacy of sugammadex versus neostigmine for the reversal of neuromuscular blockade in children. Anesth Analg. 2019;129(4):1. doi:10.1213/ANE.000000000000420731206441
  • MoritzA, SchmidtJ, SchreinerW, et al. Combined recurrent laryngeal nerve monitoring and one-lung ventilation using the EZ-Blocker and an electromyographic endotracheal tube. J Cardiothorac Surg. 2019;14(1):1–8. doi:10.1186/s13019-019-0927-630606216
  • SchepensT, CammuG, SaldienV, et al. Electromyographic activity of the diaphragm during neostigmine or sugammadex-enhanced recovery after neuromuscular blockade with rocuronium: A study in anaesthetised healthy volunteers. Eur J Anaesthesiol. 2015;32(1):010201. doi:10.1097/EJA.0000000000000140
  • KamPJD, GrobaraP, ProhnM, et al. Effects of sugammadex on activated partial thromboplastin time and prothrombin time in healthy subjects. Int J Clin Pharmacol Ther. 2014;52(3):227–236. doi:10.5414/CP20197624447651
  • BaileyJ, WilsonM, AkuffoN, et al. Evaluation of sugammadex vs neostigmine in the reversal of neuromuscular blockade. Chest J. 2018;154(4):890. doi:10.1016/j.chest.2018.08.799
  • KentNB, S SL, PhillipsS, et al. Therapeutic doses of neostigmine, depolarising neuromuscular blockade and muscle weakness in awake volunteers: a double-blind, placebo-controlled, randomised volunteer study. Anaesthesia. 2018;73(9):1079–1089. doi:10.1111/anae.1438630132821
  • Nguyen-LeeJ, MorelandN, SadoughiA, et al. Sugammadex: clinical Pharmacokinetics and Pharmacodynamics. Curr Anesthesiol Rep. 2018;4(8):168–177. doi:10.1007/s40140-018-0266-5
  • WelliverM, McDonoughJ, KalynychN, RedfernR. Discovery, development, and clinical application of sugammadex sodium, a selective relaxant binding agent. Drug Des Devel Ther. 2009;6(2):49–59.
  • Abad-GurumetaA. Evidence of residual neuromuscular block with sugammadex vs neostigmine. Br J Anaesth. 2018;120(3):603. doi:10.1016/j.bja.2017.12.02029452819
  • OkLI, SungKY, WoneCH, et al. In vitro investigation of the effects of exogenous sugammadex on coagulation in orthopedic surgical patients. BMC Anesthesiol. 2018;18(1):56–62. doi:10.1186/s12871-018-0519-329793426
  • CarronM, BertiniD, PrandiniT, et al. Effect of sugammadex on coagulation as detected by rotational thromboelastometry in morbidly obese patients. Minerva Anestesiol. 2017;84(2):178–188. doi:10.23736/S0375-9393.17.11856-028714298
  • RolienB, van LieropM-J, de KamP-J. A PK-PD model-based assessment of sugammadex effects on coagulation parameters. European J Pharmaceutical Sci. 2016;84:9–17. doi:10.1016/j.ejps.2015.12.028
  • CalòPG, MedasF, ConzoG, et al. Intraoperative neuromonitoring in thyroid surgery: is the two-staged thyroidectomy justified? Int J Surg. 2017;41(Suppl 1):S13‐S20. doi:10.1016/j.ijsu.2017.02.001
  • ChenHK, ChenCL, WenKS, et al. Application of transoral continuous intraoperative neuromonitoring in natural orifice transluminal endoscopic surgery for thyroid disease: a preliminary study. Surg Endosc. 2018;32(1):517–525. doi:10.1007/s00464-017-5656-028643050